This is reflected by the association of SETD1B levels with the global stemness signature as KD of SET1DB simultaneously altered the expression of characteristic stemness marker genes, suggesting that SETD1B is capable of systematically reprogramming HCC cells into pernicious cancer stem cells. The gene discussed is SETD1B; the disease is hepatocellular carcinoma.